Profil
Yi Shi was the founder of IC Holdings Group, Inc., founded in 2001, serving as Member.
Dr. Shi is the founder of LAV Management Co., Ltd., founded in 2008, serving as Managing Director.
Dr. Shi is currently Director at Novast Holdings Ltd., Ansun Biopharma, Inc. since 2018, SciNeuro Pharmaceuticals Ltd., Elpiscience Biopharma Ltd., Beida Pharmaceutical Co., Ltd., and LAV Asset Management (Hong Kong) Ltd. Former positions include Director at Innovent Biologics, Inc., Terns Pharmaceuticals, Inc., and Transcenta Holding Ltd. Education includes an MBA and a doctorate from Duke University.
Aktive Positionen von Yi Shi
| Unternehmen | Position | Beginn |
|---|---|---|
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV invests in companies located in China and the United States. The firm targets companies operating in the fields of biopharmaceuticals, human therapeutics, medical devices and diagnostics. It provides financing for seed, early and later stage capital requirements. | Gründer | 01.01.2008 |
Novast Holdings Ltd.
Novast Holdings Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direktor/Vorstandsmitglied | - |
Ansun Biopharma, Inc.
Ansun Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direktor/Vorstandsmitglied | 14.05.2018 |
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Develops cutting-edge immunotherapies to fight cancer | Direktor/Vorstandsmitglied | - |
Beida Pharmaceutical Co., Ltd. | Direktor/Vorstandsmitglied | - |
SciNeuro Pharmaceuticals Ltd.
SciNeuro Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which develops groundbreaking therapies for neurodegenerative diseases | Direktor/Vorstandsmitglied | - |
LAV Asset Management (Hong Kong) Ltd.
LAV Asset Management (Hong Kong) Ltd. Investment ManagersFinance Provides investment advice | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Yi Shi
| Unternehmen | Position | Ende |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | - |
Ic Holdings Group, Inc.
Ic Holdings Group, Inc. Internet Software/ServicesTechnology Services Operates as an online platform to deliver solutions for reserach and development organizations | Gründer | - |
| ░░░░░░░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Yi Shi
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Ic Holdings Group, Inc.
Ic Holdings Group, Inc. Internet Software/ServicesTechnology Services Operates as an online platform to deliver solutions for reserach and development organizations | Technology Services |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novast Holdings Ltd.
Novast Holdings Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV invests in companies located in China and the United States. The firm targets companies operating in the fields of biopharmaceuticals, human therapeutics, medical devices and diagnostics. It provides financing for seed, early and later stage capital requirements. | Finance |
Innovent Biologics, Inc.
Innovent Biologics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Ansun Biopharma, Inc.
Ansun Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Terns Pharmaceuticals, Inc.
Terns Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small-molecule product candidates to address serious diseases including oncology and obesity | Health Technology |
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Develops cutting-edge immunotherapies to fight cancer | Health Technology |
Transcenta Holding Ltd.
Transcenta Holding Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company that manufactures and wholesales pharmaceutical products | Health Technology |
Beida Pharmaceutical Co., Ltd. | |
LAV Asset Management (Hong Kong) Ltd.
LAV Asset Management (Hong Kong) Ltd. Investment ManagersFinance Provides investment advice | Finance |
SciNeuro Pharmaceuticals Ltd.
SciNeuro Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which develops groundbreaking therapies for neurodegenerative diseases | Health Technology |
















